This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Thiele, E. A. Search for Related Content PubMed PubMed Citation Articles by Thiele, E. A. Social Bookmarking                         What's this?

Managing Epilepsy in Tuberous Sclerosis Complex

Department of Neurology, Harvard Medical School, and the Pediatric Epilepsy Program, Massachusetts General Hospital, Boston, MA, ethiele{at}partners.org

Epilepsy is very common in tuberous sclerosis complex and occurs in 80 to 90% of affected individuals during their lifetime. Onset usually occurs during childhood, and up to one third of children with tuberous sclerosis complex will develop infantile spasms. Although not completely understood, the incidence of epilepsy is thought to relate to the neuropathologic features of the disorder, including cortical tubers and other dysgenetic features. Individuals with tuberous sclerosis complex frequently have epileptiform features to their electroencephalograms. Treatment of epilepsy in tuberous sclerosis complex is similar to epilepsy resulting from other causes and includes anticonvulsant medications, the vagus nerve stimulator, and the ketogenic diet. Vigabatrin has been shown to be particularly effective in treating infantile spasms in the setting of tuberous sclerosis complex. Epilepsy surgery has a very important role in the management of children and adults with pharmacoresistant epilepsy in tuberous sclerosis complex. (J Child Neurol 2004;19:680—686).

Journal of Child Neurology, Vol. 19, No. 9, 680-686 (2004)
DOI: 10.1177/08830738040190090801


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

				S. W. Way, J. McKenna III, U. Mietzsch, R. M. Reith, H. C.-j. Wu, and M. J. Gambello Loss of Tsc2 in radial glia models the brain pathology of tuberous sclerosis complex in the mouse Hum. Mol. Genet., April 1, 2009; 18(7): 1252 - 1265. [Abstract] [Full Text] [PDF]

				C. J. Chu-Shore, P. Major, M. Montenegro, and E. Thiele Cyst-like tubers are associated with TSC2 and epilepsy in tuberous sclerosis complex Neurology, March 31, 2009; 72(13): 1165 - 1169. [Abstract] [Full Text] [PDF]

				D. Dworakowska and A. B Grossman Are neuroendocrine tumours a feature of tuberous sclerosis? A systematic review Endocr. Relat. Cancer, March 1, 2009; 16(1): 45 - 58. [Abstract] [Full Text] [PDF]

				R. Nass and P. B. Crino Tuberous sclerosis complex: A tale of two genes Neurology, March 18, 2008; 70(12): 904 - 905. [Full Text] [PDF]

				L. Meikle, D. M. Talos, H. Onda, K. Pollizzi, A. Rotenberg, M. Sahin, F. E. Jensen, and D. J. Kwiatkowski A Mouse Model of Tuberous Sclerosis: Neuronal Loss of Tsc1 Causes Dysplastic and Ectopic Neurons, Reduced Myelination, Seizure Activity, and Limited Survival J. Neurosci., May 23, 2007; 27(21): 5546 - 5558. [Abstract] [Full Text] [PDF]

				P. B. Crino, K. L. Nathanson, and E. P. Henske The Tuberous Sclerosis Complex. N. Engl. J. Med., September 28, 2006; 355(13): 1345 - 1356. [Full Text] [PDF]

				P. Prather and P. J. de Vries Behavioral and Cognitive Aspects of Tuberous Sclerosis Complex J Child Neurol, September 1, 2004; 19(9): 666 - 674. [Abstract] [PDF]